SWOG/X
May 3, 2025, 18:44
SWOG launches S2312 Clinical Trial testing chemo combination in aggressive variant prostate cancer
SWOG Cancer Research Network, shared a post on X about a recent clinical trial:
“Clinical Trial S2312 tests a combination of chemo drugs for castrate-resistant prostate cancer.
Participants receive tumor testing to find out if their cancer is aggressive variant prostate cancer.
Visit swog.org or call 1-800-4-CANCER.”
More posts featuring prostate cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 8, 2025, 13:38
Jul 8, 2025, 13:27
Jul 8, 2025, 13:19
Jul 8, 2025, 12:55
Jul 8, 2025, 12:23